Earlier Egg Introduction Linked to Lower prevalence of Egg Allergy: Study

Written By :  Dr Riya Dave
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2026-06-18 16:00 GMT   |   Update On 2026-06-18 16:00 GMT
Advertisement

This population-based study found that updated infant feeding guidelines in Australia recommending earlier introduction of egg were associated with both earlier egg consumption in infants and a measurable reduction in the prevalence of egg allergy. The findings provide real-world evidence that food allergy prevention guideline updates, when informed by randomized clinical trials and implemented effectively, can contribute to reducing food allergy prevalence at the population level. The study was published in JAMA Pediatrics by Jennifer J. and colleagues.

In order to scientifically assess the overall population effect due to this important shift in policy recommendations, a highly accurate cross-sectional study examining children ages 11 to 15 months at two different points chronologically was carefully developed by the researchers. The study design included using exactly the same patient recruitment process throughout both time frames. This consisted of recruiting parents who brought their child in for his or her regular 12-month child vaccination appointments held in special vaccine centers located in Melbourne, Australia. One sample represented baseline data prior to the shift in guidelines (2007-2011) whereas the other group represented the population after the guidelines had been established (2018-2019).

Family demographic data, known risk factors associated with allergies, exact age of egg consumption, and physical symptoms were collected using parent questionnaires. In order to isolate a true statistical correlation, direct regression standardization techniques were used to determine the expected number of allergies in 2018-2019 had there been the same baseline risk distribution as existed from 2007-2011, while multiple imputation was used to overcome missing data. The data analysis process occurred from March 2025 to March 2026.

Key findings:

  • Of the 9,500 infant-parent dyads that were eligible and sent letters to be part of the study, a total of 7,209 infants from both study cohorts were finally selected.
  • Both eras had a similar response rate, with each having 76% of the eligible infant-parent pair participating in the study.
  • For the pre-guideline era (2007-2011), there were a total of 5,276 infants aged 12.4 months with 50.8% males (2,665 out of 5,244).
  • For the post-guideline era (2018-2019), there were a total of 1,1933 infants aged 12.5 months with 51.8% males (1,001 out of 1,932).
  • The median age when parents started giving egg to infants was significantly reduced from 8 months in the pre-guideline era to 6 months in the post-guideline era.
  • After adjustment for all known allergy risk factors, the population prevalence of egg allergy was observed to decrease significantly from 9.2% to 7.6% from the pre-guideline era to the post-guideline era, showing an absolute reduction of 1.6 percentage points.
  • From the highly susceptible group with childhood eczema, egg allergy dropped from 34.6% to 21.9%, showing a massive adjusted absolute difference of 12.7 percentage points.

In summary, this paper has provided population-level data showing that the updated guidelines for infant feeding which suggested introducing egg to babies early were effective in reducing the prevalence of egg allergy in the population. It appears from this study that the update of guidelines based on evidence from randomized trials can potentially be associated with a reduction in the prevalence of food allergy. This study has provided a crucial base for evidence-based public health in modern times.

Reference:

Koplin JJ, Shifti DM, Soriano VX, et al. Egg Allergy Prevalence Before and After Guidelines for Earlier Egg Introduction. JAMA Pediatr. Published online June 08, 2026. doi:10.1001/jamapediatrics.2026.2080


Tags:    
Article Source : JAMA Pediatrics

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News